EN
HI
Cohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
15.69 L
Market Cap
11327.81 CR
LTQ@LTP
5@296.10
ATP
295.15
Var Margin
35 %
Circuit Range
231.5-347.2
Delivery %
39.18 %
Value
46.30 CR
ASM/GSM
No
Market Lot
1
Summary
At 13 Mar, 2026 | 15:45, Cohance Lifesciences share price stands at ₹296.1, showing a 6.75% 2.33 for the day. The stock’s intraday movement has stayed between ₹283.75 and ₹303.30, while on a 52-week basis it has fluctuated from ₹266.70 to ₹1250.00.
In terms of trading activity, Cohance Lifesciences has recorded a volume of 1568707 shares, with a market capitalisation of ₹382567140. The stock’s Average Traded Price (ATP) stands at ₹29515, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5,29610. The stock operates within a circuit range of ₹231.5-347.2, with a Value of ₹46.30 CR. The Delivery Percentage for the day is 39.18%. Additionally, Cohance Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Cohance Lifesciences Fundamentals
View MoreP/E Ratio
54.95
P/B Ratio
2.9
Div. Yield
0
Sector P/E
60.72
Sector P/B
2.7
Sec. Div. Yield
0.58
Cohance Lifesciences Resistance and Support
Pivot 288.52
Resistance
First Resistance
294.79
Second Resistance
300.22
Third Resistance
306.49
Support
First Support
283.09
Second Support
276.82
Third Support
271.39
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
Cohance Lifesciences News
National Company Law Tribunal clears Casper Pharma’s merger with Suven Pharmaceuticals
Oct 30 2024 05:57:11
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Mr. Vivek Sharma | Executive Chairman |
| Dr. V Prasada Raju | Managing Director |
Cohance Lifesciences Similar Stocks
Caplin Point Laboratories Ltd.
1662.20
-25.40 (1.51%)
Alivus Life Sciences Ltd.
944.90
5.50 (0.59%)
Rainbow Children's Medicare Ltd.
1132.70
-41.30 (3.52%)
Concord Biotech Ltd.
1182.20
7.70 (0.66%)
Sanofi Consumer Healthcare India Ltd.
4192.90
-164.10 (3.77%)
CORONA Remedies Ltd.
1538.60
-50.00 (3.15%)
Metropolis Healthcare Ltd.
1810.00
-13.90 (0.76%)
Vijaya Diagnostic Centre Ltd.
930.80
-24.70 (2.59%)
Park Medi World Ltd.
192.56
-6.15 (3.09%)
Procter & Gamble Health Ltd.
4849.40
-39.90 (0.82%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 296.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 54.95. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 2.9. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 60.72 & 2.7 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 11327.81 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1250.00 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
